3 Stocks I Saw on T...
Rockwell Medical Technology Inc. (RMTI: NASDAQ)
$11.61 0.36 | 3.20%
02/09/12 - 03:59 PM ET
77.36K / 71.10K
Vol / Avg. Vol:11.25 / 11.25
Open / Prev. Close:10.99 - 11.75
Today's Range:6.80 - 16.91
52 Wk Range:37.07%
Performance YTD:TheStreet Rating:
Portfolios with RMTI
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserScott Mad
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorCharts of the Week - 6-26-2009
Latest RMTI Headlines from TheStreet
- Rockwell Medical Announces New Supply Agreement With DaVita Inc. 03.28.11 | 07:03 am
- Rockwell Medical Starts Pivotal Phase III Clinical Study For Treatment Of Iron Deficiency In Dialysis Patients 03.24.11 | 07:03 am
- Rockwell Medical Reports Fourth Quarter And Full Year 2010 Results 03.03.11 | 07:03 am
- Rockwell Medical Schedules Investor Conference Call 02.24.11 | 04:02 pm
- Rockwell Medical To Present At Citi 2011 Global Health Care Conference 02.23.11 | 07:02 am
- Rockwell Medical Commences PRIME Clinical Study; ESA Sparing Examined In Hemodialysis Patients Receiving SFP-Iron 02.16.11 | 07:02 am
- Rockwell Medical Announces Largest Dialysis Organizations In U.S. To Participate In Phase III CRUISE Studies 01.25.11 | 08:01 am
- Rockwell Medical Presents New Data On Proprietary Iron-Delivery Drug SFP At American Society Of Nephrology Annual Meeting 11.19.10 | 07:11 am
- Rockwell Medical To Present At The Annual Piper Jaffray Health Care Conference 11.17.10 | 09:11 am
- Rockwell Medical Reports Third Quarter Results 11.04.10 | 07:11 am
Press Releases for RMTI
- LifeSci Advisors Initiates Coverage On Rockwell Medical - Business Wire 06.10.10 | 07:06 am
Partner Headlines for RMTI
- UPDATE 1-Rockwell Medical anemia drug fails efficacy goal - Reuters 02.25.10 | 06:02 pm





